IRIS
SIROLLI, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.257
EU - Europa 2.807
AS - Asia 2.006
SA - Sud America 169
AF - Africa 24
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.210
SG - Singapore 709
CN - Cina 678
IT - Italia 527
IE - Irlanda 482
UA - Ucraina 452
SE - Svezia 353
TR - Turchia 323
GB - Regno Unito 258
DE - Germania 238
FR - Francia 209
IN - India 176
BR - Brasile 151
FI - Finlandia 107
RU - Federazione Russa 81
VN - Vietnam 37
CA - Canada 36
HK - Hong Kong 28
CZ - Repubblica Ceca 19
BE - Belgio 18
NL - Olanda 18
AT - Austria 12
IR - Iran 11
BD - Bangladesh 10
PL - Polonia 9
JP - Giappone 8
AU - Australia 7
EG - Egitto 7
ES - Italia 7
EU - Europa 6
MX - Messico 6
ZA - Sudafrica 6
DZ - Algeria 5
EC - Ecuador 4
IL - Israele 4
UZ - Uzbekistan 4
VE - Venezuela 4
AR - Argentina 3
EE - Estonia 3
JO - Giordania 3
TW - Taiwan 3
DK - Danimarca 2
LT - Lituania 2
PA - Panama 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SM - San Marino 1
SN - Senegal 1
SO - Somalia 1
Totale 8.277
Salva come PNG Salva come JPEG
Città #
Chandler 522
Jacksonville 514
Dublin 480
Singapore 470
Houston 307
Princeton 209
Southend 206
Izmir 160
Nanjing 142
Ashburn 140
Chieti 137
Dearborn 125
Beijing 112
Wilmington 82
Cambridge 81
Ann Arbor 77
Nanchang 75
The Dalles 65
Altamura 64
Santa Clara 61
Tongling 60
Los Angeles 45
New York 44
Boardman 42
Munich 41
Woodbridge 35
Hebei 32
Shenyang 32
Dong Ket 30
Washington 29
Hong Kong 27
Kunming 25
Tianjin 24
Pescara 23
Jiaxing 21
Brussels 18
Helsinki 18
Milan 18
Brno 17
Jinan 17
Kocaeli 17
Ottawa 17
Changsha 16
Nuremberg 16
Düsseldorf 15
Rome 14
Hangzhou 13
Norwalk 13
São Paulo 13
San Mateo 12
Augusta 11
Leawood 11
Shanghai 11
Zhengzhou 11
Ardabil 10
Bari 10
Hefei 10
Ningbo 10
Catania 8
Guangzhou 8
Paris 8
Seattle 8
Brooklyn 7
Cairo 7
Frankfurt am Main 7
Lanzhou 7
Turku 7
Vienna 7
Amsterdam 6
Atlanta 6
Bologna 6
Boston 6
Canberra 6
Council Bluffs 6
Falls Church 6
Grevenbroich 6
Lappeenranta 6
Naples 6
San Francisco 6
Stockholm 6
Tokyo 6
Carmiano 5
Chennai 5
London 5
Orange 5
Porto Alegre 5
Rio de Janeiro 5
Romola 5
Vittuone 5
Warsaw 5
Algiers 4
Belo Horizonte 4
Charlotte 4
Chicago 4
Hanoi 4
Montreal 4
Muzzana del Turgnano 4
Pune 4
Taizhou 4
Taranto 4
Totale 5.094
Salva come PNG Salva come JPEG
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 407
Quali soluzioni future per la dialisi peritoneale? 165
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 145
Plasma protein carbonylation in chronic uremia 132
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 128
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 127
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 125
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 124
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 123
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 123
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 121
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 119
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 119
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 115
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 114
Proteomics characterization of protein adsorption onto hemodialysis membranes 111
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 110
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 110
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 107
Effect of erythropoietin on primed leucocyte expression profile. 107
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 105
Update sull'impiego della proteomica in emodialisi 105
Proteomic Investigations into Hemodialysis Therapy 104
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 102
In vitro microbiology studies on a new peritoneal dialysis connector 102
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 101
Examining hemodialyzer membrane performance using proteomic technologies 101
Biocompatibility of DIAPES 98
Blood cell proteomics in chronic kidney disease 98
Uremic toxicity and anemia 97
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 97
null 96
Use of oral hypoglycemic agents in patients with chronic kidney failure 95
Urinary Peptidomic Biomarkers in Kidney Diseases 95
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 92
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 91
L-carnitine in uremic anemia 91
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 91
Removal of uremic plasma factors using different dialysis modalities 90
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 90
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 89
Vascular inflammation in end-stage renal disease: the red blood cell connection 88
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 88
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 87
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 87
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 87
Glomerulopathies associated with psoriasis: a report of three cases 87
New treatment approaches for the anemia of CKD 86
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 86
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 85
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 84
Management of IgA nephropathy 83
Proteomic analysis of protein adsorption onto haemodialysis membranes 83
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis 82
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 80
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 79
null 79
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 77
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 77
null 74
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 74
Interactions between platelets and leukocytes during hemodialysis 73
Proteomics and nephrology 73
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 73
Surface Antigen Expression and Platelet Neutrophil Interactions in Haemodialysis 72
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 72
Rene e Gravidanza 72
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 71
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 71
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 71
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations 71
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 70
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist 69
Malattie renali cistiche 69
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 69
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 69
L'angiodisplasia gastroenterica nel paziente uremico in trattamento emodialitico regolare. Due casi clinici 68
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 67
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? 67
L’accesso vascolare negli anziani: prevenzione o spreco di risorse? 66
Rene e paraproteine 66
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 66
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 65
Nefropatie glomerulari familiari ed ereditarie 64
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes 60
Utilità di uno screening urinario in età scolastica 60
L’uremia batte…dove il dente duole!!! 59
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 59
Prognosis of CKD patients receiving outpatient nephrology care in Italy 59
null 55
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report 52
Intensity, Duration, and Frequency of Post‐Dialysis Fatigue in Patients on Chronic Haemodialysis 52
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care 49
Treatment options for anemia in kidney transplant patients: a review 47
Post-dialysis fatigue and survival in patients on chronic hemodialysis 45
Low serum fetuin-A levels are associated with an higher cardiovascular morbidity and mortality risk in hemodialysis patients 44
Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review 43
null 42
null 41
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 40
Totale 8.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021840 110 4 97 26 87 126 8 43 79 123 75 62
2021/2022564 35 21 9 120 31 8 21 28 51 36 47 157
2022/20231.502 139 191 87 156 133 267 89 114 222 15 50 39
2023/2024812 59 20 58 32 41 280 167 30 4 20 19 82
2024/20251.762 114 246 203 90 46 71 43 84 264 74 223 304
2025/2026143 143 0 0 0 0 0 0 0 0 0 0 0
Totale 9.169